Open AccessAbstract CT085: Safety of pemetrexed (Pem) plus platinum (Plat) in combination with pembrolizumab (Pembro) for metastatic nonsquamous NSCLC: A post hoc analysis of KEYNOTE-189
Author(s) -
Edward B. Garon,
Fangfang Sun,
Catherine Muehlenbein,
Jong Seung Kim,
S. Gadgeel
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-ct085
Subject(s) - medicine , discontinuation , carboplatin , pneumonitis , nausea , placebo , meddra , population , adverse effect , pemetrexed , surgery , oncology , chemotherapy , cisplatin , pathology , alternative medicine , environmental health , lung , pharmacovigilance